Intrauterine Device Insertion Clinical Trials

Clinical trials related to Intrauterine Device Insertion Procedure

Cluster Randomized Controlled Trial of the Mittin Intervention in Addis Ababa, Ethiopia

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this clinical trial is to learn if the Mittin intervention can improve women's ability to manage their fertility in line with their preferences among women aged 15-49 using hormonal contraceptives or intrauterine devices and attending public health centers in Addis Ababa, Ethiopia. The main question it aims to answer is: Does the Mittin intervention increase preference-aligned fertility management, contraceptive method satisfaction, and preferred contraceptive method use among participants compared to standard care? Researchers will compare women's outcomes in health centers providing the Mittin intervention to women's outcomes in health centers that offer standard care to see if Mittin improves women's ability to act in line with their contraceptive preferences. Participants will * Receive either standard contraception services (control arm) or enhanced services (intervention arm) * Participate in a survey at the beginning of the study * Participate in surveys 4 and 8 months later

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 15
Maximum Age: 49
Healthy Volunteers: f
View:

• Woman

• Started or continued using hormonal contraceptive method or copper IUD on day of recruitment

• Ages 15-49 years

• Willing to provide phone number and receive follow-up phone call

Locations
Other Locations
Ethiopia
St. Paul's Hospital Millennium Medical College
RECRUITING
Addis Ababa
Contact Information
Primary
Kelsey Holt, ScD
kelsey.holt@ucsf.edu
617-455-2693
Time Frame
Start Date: 2026-02-23
Estimated Completion Date: 2027-06
Participants
Target number of participants: 2715
Treatments
No_intervention: Standard of care arm
Health centers randomized to the standard of care arm will continue offering standard of care contraceptive counseling as per Ethiopian Ministry of Health guidelines. After completion of the c-RCT, the control arm health centers will receive Mittin materials for use on-site (counseling tools, waiting room posters, and educational handouts).
Experimental: Mittin Intervention arm
Health centers randomized to receive the Mittin intervention will receive staff training and materials (counseling tools, waiting room posters, and educational handouts) necessary to offer Mittin's side effects counseling and support model in their facilities. Women enrolled in the study in intervention health centers will receive proactive follow-up calls from call center agents to offer support after initiating a new contraceptive method. The call center will also be available on-demand to any person who desires support related to contraceptive options or side effects.
Related Therapeutic Areas
Sponsors
Collaborators: Bill and Melinda Gates Foundation, St. Paul's Hospital Millennium Medical College, Ethiopia
Leads: University of California, San Francisco

This content was sourced from clinicaltrials.gov